Leading animal vaccine listed companies (ranking)
Vaccine concept stocks are Zhifei Biologicals, Wantai Biologicals, Wen's shares, Fosun Pharmaceuticals, Watson Biologicals, Shanghai Pharmaceuticals, Changchun High-tech, Junshi Biologicals, Kangxinuo, Chongqing Beer and other 103 listed companies. The following editorial brings animal vaccines listed leading stocks, we take a look at it, hope to bring reference.
Animal vaccines listed leading stocks
1, Ruipu biological.
2, Kanghua biological.
3, Pleco.
1, Ruipu biological (300119): November 17 closing news, Ruipu biological opening quote 23.29 yuan, closed at 23.47 yuan. 7 days the stock price rose 7.67%, the total market value of 9.49 billion yuan.
2, kanghua biology (300841): November 17 closing news, kanghua biology this year rose down -14.98%, as of the close, the stock fell 1.21%, reported 167.85 yuan, total market value of 15.107 billion yuan, PE of 21.6.
3, puleco (603566): November 17 news, puleco 7 Shares rose 2.31% in the day, the latest report of 19.01 yuan, the price-earnings ratio of 26.4.
4, Haili Biological (300119): leading, from the point of view of the last three years of net profit, the average of the net profit of the last three years is 14,125,700 yuan, the past three years, the lowest net profit in 2020 is 8,927,000 yuan, and the highest in 2018 is 21,300,000 yuan. The company has a complete product line, strong research and development strength, leading technical service marketing model, and market sales strength has maintained the industry leading position. Animal vaccine stocks others are: aolian electronics, dabeinong, bohui innovation, tianbang shares, mingde biology, tiankang biology, jinhe biology, keqian biology, azure biology, zhongmu shares, puro pharmaceuticals, haizheng pharmaceuticals, ruipu biology and so on.
5, animal vaccine concept: the recent market pork soared, mainly because of the discovery of the African swine fever virus in the world, and then the concept of animal vaccine stocks suddenly rise. And in the recent September 10th, the Chinese Academy of Agricultural Sciences released news that: China's African swine fever vaccine development in April this year after the success of the laboratory research work in August this year, the vaccine research and development work has made new important progress. For the progress of a strain of double gene deletion of weakly virulent live vaccine, has come to the completion of laboratory safety assessment, effective testing, and breakthrough in the scale of production technology bottlenecks, has recently been to the Ministry of Agriculture and Rural Affairs of the biosafety evaluation application, is about to enter the phase of clinical trials. Now gradually into the fall, it is swine fever, influenza and other epidemics for prevention of the best season, this time the vaccine to protect the winter and spring seasons without epidemics, plays a very important role. So in recent times the concept of animal vaccine stock hair Zhang prospects may be better. And because of the impact of the plague since last year, now the market has changed the concept of pig farms have changed, is gradually the original focus on the cost of the situation, to focus on safety and animal health care.
6, the concept of animal vaccine stocks other: biological shares, Mind Bio, Xianfeng Holdings, Tiankang Biological, Haili Biological, Yongshun Biological, Keqian Biological, Dabeinong, Jinhe Biological, in the pastoral shares, and so on.
Top 10 Leading Vaccine Stocks
1 Shanghai Pharmaceuticals is a stock issued by Shanghai Pharmaceutical Group Corporation, whose subsidiary, Shanghai Crosslink, specializes in the development of antibody-coupled drugs, as well as bio-fermentation and synthesis of small molecule drugs DM1, stock code 601607.
2. Plum Blossom Biology
Meihua Bio is a stock issued by Meihua Biotechnology Group Co., Ltd. which holds a minority stake in Liaoning Aimei Biological Vaccine Technology Group Co., Ltd. which is engaged in vaccine research and development and production, stock code 600873.
3.TIANSHILI
TIANSHILI is a stock issued by TIANSHILI HOLDINGS GROUP LIMITED, whose subsidiary Jinna Bio undertakes the national influenza virus subunit vaccine project, stock code 600535.
4.Renfo Pharmaceuticals
Renfo Pharmaceuticals is a stock issued by Renfo Pharmaceuticals Group Joint Stock Co. As a top 100 enterprise in Hubei province, the company's production capacity, dosage form type, and resources are ranked No.1 in the province, stock code 600079.
5.Tiankang Bio
Tiankang Bio is a stock issued by Tiankang Bio Co. The company's business scope includes the production and sale of veterinary drugs, additive premixed feeds, feed additives, etc., stock code 002100.
Bio-vaccine leading stocks
Leading 1, Hualan Bio: the company is mainly engaged in the research and development of blood products, vaccines, genetic engineering products, production and sales.
Leader 2, Boya Bio: the company is mainly engaged in blood products.
Leading 3, Fosun Pharmaceuticals: the company is mainly engaged in drug manufacturing and research and development.
Leading 4, Watson Biological: the company's main business is human vaccine and other biotechnology drug set of research and development, production and sales.
Leader 5, Kangtai biological: the company is mainly engaged in human vaccine research and development, production and sales.
Vaccine stocks leading recent situation
Hualan Bio: leading
Nearly 5 trading days, Hualan Bio during the period of the overall rise of 11.22%, the highest price of 21.48 yuan, the lowest price of 18.01 yuan, the total market value rose by 4.397 billion.11.18 news, the main Hualan Bio funds net inflow of 318 million yuan, oversized single funds net inflow of 329 million yuan, retail funds net outflow of 235 million yuan.
Boya Bio: leading
In the last five trading days, Boya Bio has risen on five days, during which the overall rise of 10.91%. Compared with 5 trading days ago, Boya Bio's market capitalization rose 1.931 billion yuan, up 10.91%. on November 18th news, the net capital outflow of 83.4573 million yuan, the oversized net outflow of 59.818 million yuan, turnover amounted to 966 million yuan.
Fosun Pharmaceuticals: leading
In the last five trading days, the stock price rose 8.27%, the highest price of 39 yuan, the total market value rose 8.49 billion.November 18 news, Fosun Pharmaceuticals on November 18, the main fund net inflow of 753 million yuan, the super-large single net inflow of 599 million yuan, the large single net inflow of 154 million yuan, the net outflow of retail funds 503 billion yuan.
Watson Biologicals: Leading
In the last 5 days Watson Biologicals shares rose 9.52%, total market capitalization rose 7.192 billion, the current market capitalization of 75.527 billion yuan. 2022 shares fell -17.07%. Funds flow data, on November 18, the main fund net inflow of 158 million yuan, super single net outflow of 9,619,200 yuan, large single net inflow of 167 million yuan, retail fund net outflow of 164 million yuan.
Contact Bio: leading
In the last five trading days the stock price rose 5.98%, the highest price of 38.46 yuan, the total market value rose 2.544 billion.November 18 the stock main fund net inflow of 49.5109 million yuan, oversized single net inflow of 95.7885 million yuan, large single net outflow of 46.2776 million yuan, medium single net outflow of funds 16,021,100 yuan, retail funds net outflow of 33,489,800 yuan.
Hualan Bio (002007)
Hualan Bio released its Q2 2022 financial results, realizing operating revenue of 1.709 billion yuan, up 156.87% year-on-year, and net income of 349 million yuan, 72.86% year-on-year; earnings per share was 0.19 yuan.
Boya Bio (300294)
Boya Bio released its Q3 2022 financial results, realizing operating income of 684 million yuan, up -4.55% year-on-year, and net income of 139 million yuan, 10.89% year-on-year; EPS was 0.28 yuan.
Fosun Pharma (600196)
Fosun Pharma released its Q2 2022 financial results, realizing operating income of 10.958 billion yuan, up 23.18% year-on-year, and net attributable profit of 1.085 billion yuan, up -33.66% year-on-year; EPS was 0.42 yuan.
Watson Bio (300142)
Watson Bio released its Q3 2022 financial results, realizing operating income of 1.358 billion yuan, up 74.24% year-on-year, with net profit of 110 million yuan, 144.35% year-on-year; EPS was 0.07 yuan.
Contact Bio (300601)
Contact Bio released its Q3 2022 financial results, realizing operating income of 737 million yuan, up -44.36% year-on-year, with a net profit of 82.6443 million yuan, -88.19% year-on-year; earnings per share were 0.07 yuan.
Vaccine-related stocks what else
1, Tiantan Biological (600161): the company is mainly engaged in the research, production and operation of biological products.November 18 closing news, Tiantan Biological closed at 24.660 yuan, up 9.99%. Gained this year fell -19.1%, the total market value of 40.635 billion yuan.
2, Shenzhou cell (688520): the company is engaged in biological drugs. November 18 news, Shenzhou cell-U this year rose 37.54%, the latest at 94.270 yuan, up 9.36%, turnover of 399 million yuan.
3, Junshi biological (688180): the company's main business is biopharmaceuticals. November 18 news, Junshi biological - U5 days the share price rose 3.33%, the latest at 72.410 yuan, volume of 25,902,800 lots, the total market capitalization of 66.101 billion yuan.
4, KangXinuo (688185): the company is engaged in the research and development, production of vaccines. November 18 news, KangXinuo latest offer 238.580 yuan, 3 days the share price rose 8.84%; this year's rise fell -16.52%, price-earnings ratio of 30.82.
5, Weiguang biological (002880): the company is mainly engaged in biological products. November 18th news, Weiguang biological opening quote 27.71 yuan, closed at 29.230 yuan. 5 days the stock price rose 4.86%, the total market value of 6.629 billion yuan.
6, Jindike (688670): the company is engaged in human vaccine research and development, production and sales. November 18 Jindike opening quote 50.45 yuan, closed at 52.500 yuan, up 5.02%. The day's highest price of 54.65 yuan, the lowest reached 48.51 yuan, volume of 2.641 million lots, the total market value of 4.62 billion yuan.
7, Hualan Vaccine (301207): the company is engaged in building materials, real estate, financial and pharmaceutical business. 11/18 closing news, Hualan Vaccine 5 days the stock price rose 8.71%, this year's gains fell -29.23%, the latest 54.400 yuan, up 4.43%, P/E ratio of 31.54.
8, Yatai Group ( 600881): the company's main business is single-use medical equipment. 11/18 closing news, Yatai Group latest report 2.680 yuan, up 4.28%. Volume of 80,577,500 hands, total market capitalization of 8.707 billion yuan.